Freed trades contract size for speed

Diving deeper into

Freed

Company Report
this "bottom of the market" approach limits revenue per customer, it has enabled faster adoption and helped Freed avoid the lengthy enterprise sales cycles
Analyzed 3 sources

Freed is trading contract size for speed, which is exactly why it has been able to grow with far less capital than hospital first rivals. A solo doctor can start paying $99 per month without waiting for procurement, security review, or an EHR wide rollout. That keeps the buyer and user as the same person, but it also means most accounts start with one to a few seats instead of a system wide deployment.

  • The growth effect is visible in the numbers. Freed went from about $1M to $10M ARR in 9 months, then to $19M ARR by March 2025, reaching 17,000 clinicians while total funding was still far below enterprise peers that collectively raised more than $700M to sell into hospitals and large groups.
  • The sales cycle is different because small practices can buy like normal SMB software. In hospitals, the user is rarely the buyer, HIPAA business associate agreements pull in IT and legal, and local clinician preference can be overridden by system level decisions tied to Epic or other EHR relationships.
  • The tradeoff is limited expansion per account and more integration work across a fragmented outpatient market. Small practices have only a handful of doctors, and down market customers use many different EHRs, so Freed cannot rely on one large deployment to drive revenue the way Abridge can through Epic connected health systems.

The next step is to turn a cheap note taking tool into a broader small practice workflow product. If Freed can add pre charting, coding, payments, and deeper EHR connectivity, it can raise revenue per clinician without abandoning the fast self serve motion that made adoption work in the first place.